KATRENA BLACKWELL: Open Payments
NPI 1205918224 · HOPKINSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,122 in 78 payments from 9 companies in 2025. Trend: 2023 $1,190 · 2024 $1,293 · 2025 $1,122
Food & beverage: $1,122
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $221 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $218 |
| E.R. Squibb & Sons, L.L.C. | 13 | $190 |
| Janssen Pharmaceuticals, Inc | 12 | $171 |
| Neurocrine BioSciences, Inc. | 7 | $149 |
| Vanda Pharmaceuticals Inc. | 4 | $86 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Alkermes, Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, COBENFY, INVEGA SUSTENNA, INGREZZA, FANAPT, UZEDY, ARISTADA.
Industry payments across KY — which companies pay providers there.
